Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 405

recruiting
3 974
countries
28
conditions
2 109

10 386 trials match your criteria

Systemic lupus erythematosus+1

Not yet recruiting

Study of CC-97540 CD19-targeted CAR T cells in patients with systemic lupus erythematosus who did not respond to previous immunosuppressive treatment

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:CC-97540

Analgesic therapy

Not yet recruiting

Evaluation of opioid use with nociceptive monitoring in intensive care patients receiving deep sedation with isoflurane, propofol, and midazolam

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Acute myocardial infarction

Not yet recruiting

Study of early dapagliflozin treatment to reduce heart damage in patients with acute heart attack and reduced heart pumping function

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Myocarditis

Not yet recruiting

Study of anakinra compared to placebo for treating acute myocarditis in children admitted to intensive care units

Registered drug
Countries:FranceFrance
  • Participants:0–17 years

Analgesic therapy

Not yet recruiting

Evaluating the effectiveness of icatibant in reducing propofol injection pain in healthy adult volunteers

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · Healthy volunteers
  • Substances:Icatibant

Skin dystrophy+1

Not yet recruiting

Study of botulinum toxin type A injections to prevent scarring in patients after heart surgery with sternotomy

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Atrial fibrillation

Not yet recruiting

Comparison of Etacizine and Propafenone for maintaining normal heart rhythm in patients with atrial fibrillation

Registered drugNo placebo
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Ethacizine

First study of TTX-381 gene therapy safety in patients with eye problems caused by CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2)

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
Countries:FranceFrance
  • Participants:0–17 years

Study of obinutuzumab to reduce PLA2R antibodies in patients with primary membranous nephropathy

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years

Cutaneous T-cell lymphoma

Not yet recruiting

Study of brentuximab vedotin for maintenance therapy in patients with cutaneous T-cell lymphoma after stem cell transplant

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years

Febrile neutropenia

Not yet recruiting

Comparing amoxicillin-clavulanate alone versus amoxicillin-clavulanate with ciprofloxacin for treating chemotherapy-induced fever in adult hematology patients

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.